Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 228,698 | 169,286 | 245,406 | 115,374 | 147,449 |
| Marketable Securities | N/A | N/A | 49,943 | N/A | N/A |
| Receivables | 66,845 | 124,435 | 39,115 | 104,872 | 39,109 |
| Inventories | 61,017 | 88,242 | 104,603 | 111,854 | 116,349 |
| TOTAL | $371,437 | $391,000 | $449,102 | $340,756 | $309,533 |
| Non-Current Assets | |||||
| PPE Net | 8,622 | 8,821 | 9,380 | 9,855 | 10,380 |
| Intangibles | 199,223 | 206,431 | 212,537 | 337,165 | 346,265 |
| Other Non-Current Assets | 64,857 | 69,891 | 74,155 | 99,943 | 105,023 |
| TOTAL | $272,702 | $285,143 | $296,072 | $446,963 | $461,668 |
| Total Assets | $644,139 | $676,143 | $745,174 | $787,719 | $771,201 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 41,308 | 40,403 | 29,413 | 54,379 | 39,217 |
| Accrued Expenses | 130,624 | 123,021 | 142,832 | 124,887 | 129,071 |
| TOTAL | $187,146 | $181,458 | $195,774 | $214,152 | $208,118 |
| Non-Current Liabilities | |||||
| Long Term Debt | 96,378 | 76,608 | 76,338 | 76,072 | 75,805 |
| Deferred Revenues | 15,214 | 18,034 | 23,529 | 34,886 | 39,830 |
| Other Non-Current Liabilities | 87,652 | 66,455 | 68,260 | 58,332 | 59,401 |
| TOTAL | $209,375 | $176,723 | $179,140 | $177,203 | $168,326 |
| Total Liabilities | $396,521 | $358,181 | $374,914 | $391,355 | $376,444 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 153,502 | 144,539 | 143,317 | 130,266 | 129,858 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -1,177,511 | -1,090,511 | -1,030,552 | -854,801 | -794,054 |
| Other shareholders' equity | 13 | 6 | -9 | 0 | 0 |
| TOTAL | $247,618 | $317,962 | $370,260 | $396,364 | $394,757 |
| Total Liabilities And Equity | $644,139 | $676,143 | $745,174 | $787,719 | $771,201 |